The Trump administration’s healthcare policy changes from the gutting of medical research grants to changes on the CDC vaccine board were the focus of the discussion on the latest episode of the Debunked Podcast with MedCity News Editor-in-Chief Arundhati Parmar and Samir Batra, managing partner of Health Innovation Pitch. The post Debunked Episode 17: Is…
Rural hospitals are facing growing cybersecurity threats and digital demands but often lack the resources to respond — a gap Microsoft is working to close through discounted tools, free training and an AI innovation lab. The tech giant’s rural health initiative has reached more than 700 hospitals so far. The post How Microsoft Is Sparking…
Novartis’s Cosentyx failed to beat a placebo in a Phase 3 clinical trial in giant cell arteritis. The antibody drug was being developed as an alternative to Roche and AbbVie drugs whose approved uses include treating this autoimmune disorder affecting blood vessels. The post Blockbuster Novartis Drug Fails Key Test Hoped to Expand Its Use…
From mobile documentation to emergency handoffs, EMS providers handle sensitive patient information in fast-moving environments. Understanding how HIPAA applies — and how to comply — can improve care, reduce risk, and build systemwide trust. The post Why HIPAA Compliance Is Both a Challenge and Opportunity for EMS Providers appeared first on MedCity News.
Drastic cuts to Medicaid and Medicare proposed by Congress will increase wait times, result in more fragmented or nonexistent care, and cause unnecessary deaths and despair. The post For the Sake of their Constituents, Congress Should Increase Medicare Payments and Oppose Deep Cuts to Medicaid appeared first on MedCity News.
Inaccuracies don’t just erode trust — they lead directly to surprise billing events, missed appointments, care delays, and in some cases, enforcement action. The post Beyond Broken Links: The High Stakes of Provider Directory Accuracy in the No Surprises Era appeared first on MedCity News.
A systemic change from FFS to VBC would represent more than a payment model switch, but rather a holistic transition toward patient-centered healthcare that prioritizes outcomes over activity. The post From Fee-for-Service to Value-Based Care: Enhancing Outcomes in Nephrology appeared first on MedCity News.
Dizal Pharmaceutical’s Zegfrovy is now FDA approved for treating non-small cell lung cancer driven by a particular rare genetic signature. Johnson & Johnson drug Rybrevant already addresses this genetic signature as an earlier line of therapy, but Dizal executives contend their drug offers the potential for better safety and efficacy. The post With FDA Nod…
This week, CMS established a reimbursement code for Eko Health’s AI platform, which seeks to aid clinicians in the diagnosis of heart conditions. The goal behind the technology is to help catch heart disease earlier, when it’s easier to treat, and to make high quality diagnostic care more accessible. The post Eko Health’s AI for…
It became clear to me that if my father’s life could be drastically improved with routine at-home care, so could many others. The next frontier in healthcare isn’t just about new medications or diagnostic tools; it’s about reimagining how and where we deploy our existing clinical expertise. The post What Administering My Father’s Home Infusions…